Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy

by Jie Yin, Jie Yin, James M. Markert, James M. Markert, James M. Markert, Jianmei W. Leavenworth, Jianmei W. Leavenworth
Published 2017-06-01

Bilateral metastatic renal hemangiopericytoma ten years after primary intracranial lesion

by Lee N. Hammontree, Kristopher Whitehead, James M. Markert
Published 2006-06-01

Histone deacetylase inhibitors improve the replication of oncolytic herpes simplex virus in breast cancer cells.

by James J Cody, James M Markert, Douglas R Hurst
Published 2014-01-01

Oncolytic Virus-Based Cytokine Expression to Improve Immune Activity in Brain and Solid Tumors

by Taylor M. Pearl, James M. Markert, Kevin A. Cassady, Mohammed G. Ghonime
Published 2019-06-01

Human Herpesviridae Methods of Natural Killer Cell Evasion

by Carl I. Odom, David C. Gaston, James M. Markert, Kevin A. Cassady
Published 2012-01-01

To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses

by Kevin A. Cassady, Kellie B. Haworth, Josh Jackson, James M. Markert, Timothy P. Cripe
Published 2016-02-01

Alteration of the threshold stimulus for intraoperative brain mapping via use of antiepileptic medications

by John W. Amburgy, MD, Robert C. Foster, BS, Neil Billeaud, MD, James M. Markert, MD
Published 2015-03-01

Preclinical Evaluation of Oncolytic Δγ134.5 Herpes Simplex Virus Expressing Interleukin-12 for Therapy of Breast Cancer Brain Metastases

by James J. Cody, Pietro Scaturro, Alan B. Cantor, G. Yancey Gillespie, Jacqueline N. Parker, James M. Markert
Published 2012-01-01

Spontaneous cerebellar hemorrhage in a patient taking apixaban

by Christopher D. Shank, MD, Esther B. Dupépé, MD, MSPH, Kara A. Sands, MD, James M. Markert, MD
Published 2015-03-01

Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy

by Gregory K Friedman, Joel eRaborn, Virginia M Kelly, Kevin A Cassady, James M Markert, George Yancey Gillespie
Published 2013-02-01

Effect of HSV-IL12 Loaded Tumor Cell-Based Vaccination in a Mouse Model of High-Grade Neuroblastoma

by David F. Bauer, Larisa Pereboeva, G. Yancey Gillespie, Gretchen A. Cloud, Osama Elzafarany, Catherine Langford, James M. Markert, Lawrence S. Lamb Jr.
Published 2016-01-01

Pre-clinical Assessment of C134, a Chimeric Oncolytic Herpes Simplex Virus, in Mice and Non-human Primates

by Kevin A. Cassady, David F. Bauer, Justin Roth, Melissa R. Chambers, Trent Shoeb, Jennifer Coleman, Mark Prichard, G. Yancey Gillespie, James M. Markert
Published 2017-06-01

Production of bioactive soluble interleukin-15 in complex with interleukin-15 receptor alpha from a conditionally-replicating oncolytic HSV-1.

by David C Gaston, Carl I Odom, Li Li, James M Markert, Justin C Roth, Kevin A Cassady, Richard J Whitley, Jacqueline N Parker
Published 2013-01-01

Chimeric HCMV/HSV-1 and Δγ134.5 oncolytic herpes simplex virus elicit immune mediated antigliomal effect and antitumor memory

by Mohammed G. Ghonime, Josh Jackson, Amish Shah, Justin Roth, Mao Li, Ute Saunders, Jennifer Coleman, G. Yancey Gillespie, James M. Markert, Kevin A. Cassady
Published 2018-02-01

Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma

by Alicia M. Waters, Laura L. Stafman, Evan F. Garner, Smitha Mruthyunjayappa, Jerry E. Stewart, Gregory K. Friedman, Jennifer M. Coleman, James M. Markert, G. Yancey Gillespie, Elizabeth A. Beierle
Published 2016-10-01

Prognostic relevance of cytochrome C oxidase in primary glioblastoma multiforme.

by Corinne E Griguer, Alan B Cantor, Hassan M Fathallah-Shaykh, G Yancey Gillespie, Amber S Gordon, James M Markert, Ivan Radovanovic, Virginie Clement-Schatlo, Chevis N Shannon, Claudia R Oliva
Published 2013-01-01

Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002

by Eric K. Ring, Rong Li, Blake P. Moore, Li Nan, Virginia M. Kelly, Xiaosi Han, Elizabeth A. Beierle, James M. Markert, Jianmei W. Leavenworth, G. Yancey Gillespie, Gregory K. Friedman
Published 2017-12-01

Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of pediatric solid tumors.

by Michael L Megison, Lauren A Gillory, Jerry E Stewart, Hugh C Nabers, Elizabeth Mroczek-Musulman, Alicia M Waters, Jennifer M Coleman, Virginia Kelly, James M Markert, G Yancey Gillespie, Gregory K Friedman, Elizabeth A Beierle
Published 2014-01-01

Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastoma.

by Lauren A Gillory, Michael L Megison, Jerry E Stewart, Elizabeth Mroczek-Musulman, Hugh C Nabers, Alicia M Waters, Virginia Kelly, Jennifer M Coleman, James M Markert, G Yancey Gillespie, Gregory K Friedman, Elizabeth A Beierle
Published 2013-01-01

Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children

by Gregory K Friedman, Elizabeth A Beierle, George Yancey Gillespie, James M Markert, Alicia M Waters, Chun-Yu Chen, Nicholas L Denton, Kellie B Haworth, Brian Hutzen, Jennifer L Leddon, Keri A Streby, Pin-Yi Wang, Timothy P Cripe
Published 2015-01-01